Author

Sieglinde Reinisch 1

1 Internal Medicine Iii, Medical University Of Vienna, Vienna, Austria;internal Medicine, Mcmaster University, Hamilton, Canada

A NOVEL SIMPLE SCORE FOR THE DIAGNOSIS OF CROHN’S DISEASE

Sieglinde Reinisch, Karin Schweiger, Eleonore Pablik, Benjamin Collet-Fenetrier, Laurent Peyrin-Biroulet, Julian Panés, Walter Reinisch

ADALIMUMAB (ADA) AND INFLIXIMAB (IFX) THERAPY DURING PREGNANCY IN IBD: A PROSPECTIVE ASSESSMENT OF OUTCOME, SAFETY, ANTI-TNFΑ CORD BLOOD AND FOLLOW UP BLOOD LEVELS IN NEWBORNS

Stefan Traussnigg, Alexander Eser, Christian Primas, Pavol Papay, Cornelia Gratzer, Andrea Mikulits, Sieglinde Reinisch, Walter Reinisch, Michael Trauner, Harald Vogelsang, Gottfried Novacek, Clemens Dejaco

ANTI-DRUG ANTIBODIES INHIBIT NEUTRALIZATION OF TNF-ALPHA IN INFLIXIMAB TREATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)

Alexander Eser, Harald Vogelsang, Sieglinde Reinisch, Gottfried Novacek, Clemens Dejaco, Lili Kazemi-Shirazi, Christian Primas, Sonja Brehovsky, Xinjun Liu, Sharat Singh, Walter Reinisch

ASSOCIATION BETWEEN ELEVEN THIOPURINE METABOLITES AND MUCOSAL HEALING IN PATIENTS WITH CROHN’S DISEASE

Sieglinde Reinisch, Ute Hofmann, Cornelia Lichtenberger, Stefan Winter, Alexander Eser, Alexander Teml, Clemens Dejaco, Gottfried Novacek, Harald Vogelsang, Elke Schäffeler, Matthias Schwab, Walter Reinisch

INFORMATION NECESSARY TO PREDICT INDIVIDUAL INFLIXIMAB (IFX) PHARMACOKINETICS (PK) IN PATIENTS WITH IBD

Alexander Eser, Harald Vogelsang, Gottfried Novacek, Sieglinde Reinisch, Christian Primas, Sonja Brehovsky, Diane R. Mould, Walter Reinisch

Item 1 - 5 / 8
1